Investing.com - Financial Markets Worldwide

Starbucks, Freeport-McMoran and Verona Pharma rise premarket; WPP, T-Mobile fall

AuthorPeter Nurse
Published 09/07/2025, 12:14
© Reuters.
C
-0.05%
MRK
-1.01%
WYNN
2.87%
SBUX
0.41%
WPP
0.36%
FCX
1.14%
AES
0.90%
HG
0.00%
WPP
0.23%
PROR
-0.18%
TMUS
-0.36%
RUN
3.61%
VRNA
0.09%
BBIO
6.03%
RXST
7.02%

Investing.com -- U.S. stock futures edged higher Wednesday in calm trading, as investors assessed the new developments in the Trump administration’s trade negotiations ahead of the release of the minutes from the last Federal Reserve meeting.

Here are some of the biggest premarket U.S. stock movers today:

  • Starbucks (NASDAQ:SBUX) stock rose 1.5% after Bloomberg reported that the coffee chain’s China business is attracting birds valuing it at up to $10 billion.

  • Freeport-McMoran (NYSE:FCX) stock rose 2.1%, with the copper producer benefiting from President Donald Trump raising the prospect of a 50% tariff on imported copper.

  • WPP (LON:WPP) (NYSE:WPP) ADRs slumped 16% after the advertising giant lowered its full-year profit guidance following a deterioration in performance during the second quarter, citing challenging economic conditions and weaker client spending.

  • Verona Pharma (NASDAQ:VRNA) stock surged 20% after Merck (NSE:PROR) (NYSE:MRK), up 0.2%, announced plans to buy the U.K.-based company for about $10 billion, strengthening the U.S. firm’s presence in respiratory treatments as it readies for the patent expiry of its blockbuster cancer drug.

  • T-Mobile US (NASDAQ:TMUS) stock fell 1.8% after KeyBanc downgraded the telecom giant to “underweight” from “sector weight”, saying its underperformance is set to continue and its “premium valuation is just too high.”

  • Wynn Resorts (NASDAQ:WYNN) stock fell 1% after Citigroup (NYSE:C) downgraded its stance on the casino company to “neutral” from “buy”, expecting it to lose near-term market share in the important Macau region.

  • Sunrun (NASDAQ:RUN) stock rose 2.7% after Jefferies upgraded the battery energy storage provider to “hold” from “underperform”, reversing the downgrade after just a month.

  • BridgeBio Pharma (NASDAQ:BBIO) stock rose 2.1% after Oppenheimer upgraded the biopharmaceutical company to “outperform” from “perform”, seeing a potential 39% upside.

  • Rxsight (NASDAQ:RXST) stock slumped 39% after the eyewear company cut its 2025 revenue forecast and reported preliminary second-quarter revenue that fell short of expectations.

  • AES (NYSE:AES) stock rose 13% after Bloomberg News reported that the power provider was exploring options including a sale.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.